Trade Mark Journal No.2026/002 9 January 2026
WO0000001893374 (5)
Office of origin: United States of America
Date of International Registration:26 November 2025
Date of designation in the UK:
26 November 2025

International priority date claimed: 9 October 2025
(United States of America)
(99435435)
- Class 5
- Pharmaceutical preparations for the treatment of liver diseases.
Mirum Pharmaceuticals, Inc.
Representative: Karl M. Zielaznicki Troutman Pepper Locke LLP, 600 Peachtree Street NE, Suite 3000,, c/o TM DKT CLK, Atlanta GA 30308, UNITED STATES OF AMERICA